Cartesian Therapeutics Strengthens Research and Innovation Leadership with appointment of Professor Christopher M. Jewell as Chief Scientific Officer
Gaithersburg, MD—February 14, 2023 – Cartesian Therapeutics, a fully integrated biopharmaceutical company pioneering RNA cell therapy for autoimmune diseases and ...